F amilial hypertrophic cardiomyopathy (HCM) is a clinically and genetically heterogenous disorder. ' Schier and Adelstein2 have shown that the peptide structures and enzymatic activities of myosins purified from HCM and control cardiac muscles are indistinguishable from one another. Molecular genetic analyses at the DNA level, however, have led to the recent identification of mutations in the myosin heavy chain (MHC) family of genes located on chromosome 14ql as likely causes of HCM in some families. [3] [4] [5] [6] [7] In the present report, we have analyzed the organization and protein composition of myofibrils in cardiac muscle biopsies of patients with HCM, including two individuals with a missense mutation of the fl-cardiac MHC gene defined at the DNA level (residue 403, Arg to Gln). HCM biopsies were similar to control biopsies with respect to myofibrillar protein content including aand f3-MHC. The observed integrity of sarcomeric A band structure is consistent with the specific f-MHC mutation resulting primarily in subclinical contractile dysfunction with hypertrophy and disarray as secondary consequences of this dysfunction.
Materials and Methods Human Muscle Tissues
Human left ventricular and septal muscle tissue was obtained from individuals undergoing cardiac transplantation or left ventricular outflow tract myomectomy for HCM at The Methodist Hospital, Houston, Tex. The individuals were diagnosed with HCM by clinical criteria and echocardiography.8 Right ventricular muscle tissue was obtained from diagnostic right heart catheterization. This protocol was approved by the Human Investigations Committees of the Baylor College of Medicine and The Methodist Hospital. All HCM specimens were examined independently by a pathologist and exhibited myocyte to myocyte disarray by brightfield microscopy of hematoxylin and eosin-stained sections. Human skeletal muscle was obtained from vastus lateralis biopsy. Tissues obtained from other institutions were processed as above, transferred to our laboratory, and stored on dry ice. Immediately after removal, samples were dissected on ice, and sample aliquots were frozen at -80°C. Additional gels transferred. After transfer, the nitrocellulose blots were incubated at room temperature for 1 hour with the respective primary antibody, followed by incubation for 1 hour with a heavy chain-and light chain-specific, affinity-purified alkaline phosphatase-conjugated goat anti-mouse immunoglobulin G (Cappel-Organon Teknika Corp., Durham, N.C.) at 0.5 ,ug/ml. The blots were developed in Tris-buffered (pH 9.5) 0.033% (wt/vol) nitro blue tetrazolium and 0.016% (wt/vol) 5-bromo-4-chloro-3-indolyl phosphate until sufficient intensity was reached. Transfer experiments with double nitrocellulose membranes indicated that only minimal amounts of MHC transferred through the first membrane.
Immunofluorescence of Skeletal Muscle Myosins
Tissue embedded in OCT was sectioned in -20°C at a thickness of 4 ,um in a Minotome cryostat. The To examine the effects of a defined fl-MHC mutation on associated myofibrillar proteins, we studied the protein composition of crude preparations of sectioned cardiac muscle from two subjects with HCM who had a predicted missense mutation in the f-MHC gene at position 403 (Arg to Gin) compared with diseased control tissue, including HCM with unknown molecular defects. Patient information is listed in Table 1 . Individual specimens were processed according to a previously described protocol suitable for small quantities of muscle.9,1"1 Despite the samples having been stored for up to 3 years, overall protein breakdown, as assessed by densitometry of MHC and actin, appeared to be low.
Once processed and stored in gel running buffer at -80°C, sample aliquots did not show any further degradation. Figure 1C shows that the major myofibrillar proteins were represented at comparable levels in both mutant /3-MHC HCM and control tissues. Densitometry of MHC and actin revealed no significant difference in their levels between the various tissue samples (Table 1, p>O.1 by analysis of variance). Although the MHC/actin ratio of the specific missense mutant was within the control range, small differences in various minor protein bands appeared consistently, as shown in lane 4 of Figure 1C .
Immunoblotting with specific monoclonal antibodies (Figure 2 ). These results were obtained routinely in unfixed samples that were frozen rapidly for biochemical analysis.
Cardiac fB-MHC Within Skeletal Myofibrils
Because of limited cardiac biopsy material from the patients with the specific missense mutation, we analyzed one patient's skeletal muscle. Figure 3 _ X a-MHC reactivity was detected in skeletal muscle by immunoblotting or immunofluorescence. Discussion Cardiac biopsies taken from two subjects with HCM who had a predicted 3-MHC mutation (403 Arg to Gln) were found to be normal in MHC composition. In these heart tissues, ,B-MHIC was assembled into organized sarcomeres, as evidenced by a regular sarcomeric structure. Cardiac /3-MHC was expressed properly in skeletal muscle of these HCM and control subjects.
Because recent reports implicate mutations in the MHC gene family as putative causes of HCM in some families,67 the examination of myocardial sarcomeric architecture and protein accumulation in persons with defined alleles has become particularly important. Since alteration of one sarcomeric component may influence the expression of other associated elements,6 we quantitated MHC and actin protein bands on SDS-PAGE by densitometry. Our results indicate that HCM samples, including samples from two subjects with a defined ,3-MHC missense head mutation, exhibit MHC/actin ratios similar to those found in control samples. Thus, it would appear that the clinical picture of HCM does not arise as a result of a failure of MHC or actin to accumulate in the myocyte. The specific missense mutants consistently show differences in the levels of minor protein bands. The cause of these small differences remains unknown; however, increased specific turnover rate in vivo or increased proteolysis of sarcomeric protein in vitro in the specific 3-MHC mutant cannot be excluded.
Geisterfer-Lowrance et a16 have hypothesized that mutations in MHCs may lead to a poisoning of the assembly of myosin into myofibrils. Our findings in two HCM patients who had the 403 Arg to Gln missense mutation of the /3-MIC gene demonstrate regular sarcomeric organization by polarized light microscopy.
These results suggest the proper assembly of f-MHCcontaining myosin molecules.
Cardiac myocyte disarray is the accepted criterion for the pathological diagnosis of HCM and is hypothesized to be closely related to its pathogenesis' l1617; however, this disarray has also been described in a variety of unrelated cardiac disorders and in apparently normal we hypothesize that subtly defective myofibrils containing the mutant myosin may fail to meet the contractile demands of a developing heart, triggering an abnormal contractile response leading to hypertrophy, the extent and location of which may be allele specific. MHC head mutations in Caenorhabditis elegans that exhibit abnormal contractility in the presence of normal sarcomere structure3132 provide an experimental model for the dissociation of intact myofibrillar structure and perturbed contractile function observed in human HCM.33
